Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.

Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, Kamada S, Saito K, Iiizumi M, Liu W, Ericsson J, Watabe K.

Cancer Res. 2008 Feb 15;68(4):1003-11. doi: 10.1158/0008-5472.CAN-07-2489.

2.

Molecular classification and correlates in colorectal cancer.

Ogino S, Goel A.

J Mol Diagn. 2008 Jan;10(1):13-27. doi: 10.2353/jmoldx.2008.070082. Epub 2007 Dec 28. Review.

3.

Fatty acid synthase inhibitors: new directions for oncology.

Kridel SJ, Lowther WT, Pemble CW 4th.

Expert Opin Investig Drugs. 2007 Nov;16(11):1817-29. Review.

PMID:
17970640
4.

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Menendez JA, Lupu R.

Nat Rev Cancer. 2007 Oct;7(10):763-77. Review.

PMID:
17882277
5.

Dietary fat-gene interactions in cancer.

Chen YQ, Edwards IJ, Kridel SJ, Thornburg T, Berquin IM.

Cancer Metastasis Rev. 2007 Dec;26(3-4):535-51. Review.

PMID:
17849170
6.

Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.

Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S.

J Clin Oncol. 2007 Sep 1;25(25):3930-5.

PMID:
17761976
7.

Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.

Zhang W, Press OA, Haiman CA, Yang DY, Gordon MA, Fazzone W, El-Khoueiry A, Iqbal S, Sherrod AE, Lurje G, Lenz HJ.

J Clin Oncol. 2007 Aug 20;25(24):3726-31.

PMID:
17704422
8.

Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression.

Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R.

J Clin Oncol. 2007 Aug 1;25(22):3313-20.

PMID:
17664480
9.

Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab.

Sartore-Bianchi A, Moroni M, Veronese S, Carnaghi C, Bajetta E, Luppi G, Sobrero A, Barone C, Cascinu S, Colucci G, Cortesi E, Nichelatti M, Gambacorta M, Siena S.

J Clin Oncol. 2007 Aug 1;25(22):3238-45.

PMID:
17664472
10.

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA 3rd, Poplin EA, Hidalgo M, Baselga J, Clark EA, Mauro DJ.

J Clin Oncol. 2007 Aug 1;25(22):3230-7.

PMID:
17664471
11.

Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.

J Mol Diagn. 2007 Jul;9(3):305-14.

12.

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Chan AT, Ogino S, Fuchs CS.

N Engl J Med. 2007 May 24;356(21):2131-42.

13.

Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS.

Hum Pathol. 2007 Jun;38(6):842-9. Epub 2007 Mar 12.

PMID:
17350669
14.

Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells.

Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ.

Cancer Res. 2007 Feb 1;67(3):1262-9.

15.

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.

Kim GP, Colangelo LH, Wieand HS, Paik S, Kirsch IR, Wolmark N, Allegra CJ; National Cancer Institute.

J Clin Oncol. 2007 Mar 1;25(7):767-72. Epub 2007 Jan 16.

PMID:
17228023
16.

Clinical uses of microsatellite instability testing in colorectal cancer: an ongoing challenge.

Boland CR.

J Clin Oncol. 2007 Mar 1;25(7):754-6. Epub 2007 Jan 16. No abstract available.

PMID:
17228016
17.

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.

Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N.

J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54.

PMID:
17105987
18.
19.

Physical activity and survival after colorectal cancer diagnosis.

Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS.

J Clin Oncol. 2006 Aug 1;24(22):3527-34. Epub 2006 Jul 5.

PMID:
16822844

Supplemental Content

Support Center